Anne A. Finucane, Director at CVS CAREMARK CORP (CVS), sold 500 shares at $57.24 ($29K) on 2013-04-15, disclosed to the SEC on 2013-04-16.
Scheduled sale ($29k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CVS | SELL | 2016-01-05 | $192K | — | Filing → |
| CVS | SELL | 2012-09-18 | $47K | — | Filing → |